Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections

被引：0
|
作者：
Dunne, Michael W. [1 ,5 ,6 ]
Aronin, Steven, I [1 ]
Das, Anita F. [2 ]
Gupta, Jayanti [1 ]
Akinapelli, Karthik [3 ]
Breen, Jeanne [1 ]
Zelasky, Michael T. [4 ]
Puttagunta, Sailaja [1 ]
机构：
[1] Iterum Therapeut, Old Saybrook, CT USA
[2] Das Stat Consulting, Guerneville, CA USA
[3] Takeda Pharmaceut, Cambridge, MA USA
[4] Johnson & Johnson, Cambridge, MA USA
[5] Bill & Melinda Gates Med Res Inst, Cambridge, MA 02115 USA
[6] Bill & Melinda Gates Med Res Inst, One Kendall Sq, Cambridge, MA 02115 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷 / 12期
关键词：
D O I：
10.1093/cid/ciad149
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2213 / 2215
页数：3
相关论文
共 50 条
  • [1] Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial
    Dunne, Michael W.
    Aronin, Steven, I
    Das, Anita F.
    Akinapelli, Karthik
    Breen, Jeanne
    Zelasky, Michael T.
    Puttagunta, Sailaja
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (01) : 78 - 88
  • [2] Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
    Howard-Anderson, Jessica
    Hamasaki, Toshimitsu
    Dai, Weixiao
    Collyar, Deborah
    Rubin, Daniel
    Nambiar, Sumathi
    Kinamon, Tori
    Hill, Carol
    Gelone, Steven P.
    Mariano, David
    Baba, Takamichi
    Holland, Thomas L.
    Doernberg, Sarah B.
    Chambers, Henry F.
    Fowler, Vance G.
    Evans, Scott R.
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1157 - E1165
  • [3] Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial
    Dunne, Michael W.
    Aronin, Steven, I
    Das, Anita F.
    Akinapelli, Karthik
    Zelasky, Michael T.
    Puttagunta, Sailaja
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (01) : 66 - 77
  • [4] Applying Desirability of Outcome Ranking End Points
    Dunne, Michael W.
    Aronin, Steven, I
    Das, Anita F.
    Gupta, Jayanti
    Akinapelli, Karthik
    Zelasky, Michael T.
    Puttagunta, Sailaja
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (01) : 159 - 161
  • [5] A RANDOMIZED TRIAL OF MECILLINAM VERSUS TOBRAMYCIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS
    KOPCHICK, JH
    JACOBS, SC
    LAWSON, RK
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (06): : 884 - 888
  • [6] Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial (vol 76, pg 66, 2022)
    Dunne
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (06) : 937 - 937
  • [7] AN OPEN TRIAL OF CEFTAZIDIME IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS
    FERREIRA, AM
    COELHO, H
    DECARVALHO, MP
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1984, 12 (06) : 361 - 363
  • [8] Cefiderocol for treatment of complicated urinary tract infections
    Wagenlehner, Florian M. E.
    Naber, Kurt G.
    LANCET INFECTIOUS DISEASES, 2019, 19 (01): : 22 - 23
  • [9] OPEN RANDOMIZED COMPARISON OF OFLOXACIN AND NORFLOXACIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS
    RUGENDORFF, EW
    DRUGS, 1987, 34 : 91 - 94
  • [10] OPEN, RANDOMIZED COMPARISON OF PEFLOXACIN AND CEFOTAXIME IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS
    TIMMERMAN, C
    HOEPELMAN, I
    DEHOND, J
    BOON, T
    SCHREINEMACHERS, L
    MENSINK, H
    VERHOEF, J
    INFECTION, 1992, 20 (01) : 34 - 37
12345